Company news
Filana Therapeutics, Inc. news
Latest news releases, newest first.
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
October 28, 2026
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
September 22, 2026
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
July 29, 2026
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
May 7, 2026
Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
May 5, 2026
Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
April 15, 2026
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 12, 2026